Hospital Acquired Infections Diagnostics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Instrument and Reagents, Consumables); Test Type (Molecular Diagnostics, Urinalysis, Immunoassay); Application (Disease Testing, Drug-Resistance Testing); Infection Type (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Others); End Users (Hospital, Clinics, Others) and Geography

Report Code: TIPRE00016871 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Hospital Acquired Infections (HAI) Diagnostics are to diagnose different hospital acquired diseases during the stay in hospital. Hospital acquired disease are the local or systemic condition or infection which usually occur by adverse effect from medicine, medical care or by coming in contact with bacteria and other toxins. Hospital acquired infection having higher mortality rates. The infection can also be due to catheter blood stream infection, infection at surgical site, pneumonia from ventilator, urinary tract infections. These infections can be acquired in OPD, clinic setting, OT, Rehabilitation center etc.

MARKET DYNAMICS

The key market drivers for Hospital Acquired Infections (HAI) Diagnostics Market Includes, increase prevalence of hospital acquired disease, rising geriatric population across the globe, rising length of stay in hospital are some of the factors which are expected to drive market growth during the forecast period. However, improvement in medical care facilities, decreased prevalence of HAI in developed countries are expected to hinder market growth during forecast period.

MARKET SCOPE

The "Hospital Acquired Infections (HAI) Diagnostics Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Hospital Acquired Infections (HAI) Diagnostics market with detailed market segmentation by product, test type, application, infection type and end user. The Hospital Acquired Infections (HAI) Diagnostics Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Hospital Acquired Infections (HAI) Diagnostics Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Hospital Acquired Infections (HAI) Diagnostics Market is segmented on the basis of product, test type, application, infection type and end user. On the basis of product the market is segmented into, instruments and consumables. On the basis of test type the market is segmented into, molecular diagnostics, urinalysis, immunoassay. On the basis of application market is segmented into, disease testing, drug-resistance testing. On basis of infection type market is segmented as, hospital acquired pneumonia, bloodstream infections, surgical site infections and other infections. And on the basis of end users the market is segmented as, hospital, clinic and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Hospital Acquired Infections (HAI) Diagnostics Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hospital Acquired Infections (HAI) Diagnostics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Hospital Acquired Infections (HAI) Diagnostics Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Hospital Acquired Infections (HAI) Diagnostics Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Hospital Acquired Infections (HAI) Diagnostics Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Hospital Acquired Infections (HAI) Diagnostics Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Hospital Acquired Infections (HAI) Diagnostics market in the global market. Below mentioned is the list of few companies engaged in the Hospital Acquired Infections (HAI) Diagnostics Market.

The report also includes the profiles of key players in Hospital Acquired Infections (HAI) Diagnostics Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Abbott Laboratories
  •   Alere,Inc
  •   BD
  •   AdvanDX
  •   Hologic,Inc
  •   AstraZeneca Plc
  •   Roche AG
  •   Bayer Schering Pharma LLC
  •   Cepheid Inc
  •   Daiichi Sankyo

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hospital Acquired Infections Diagnostics Market - By Product
1.3.2 Hospital Acquired Infections Diagnostics Market - By Test Type
1.3.3 Hospital Acquired Infections Diagnostics Market - By Application
1.3.4 Hospital Acquired Infections Diagnostics Market - By Infection Type
1.3.5 Hospital Acquired Infections Diagnostics Market - By End Users
1.3.6 Hospital Acquired Infections Diagnostics Market - By Region
1.3.6.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENT AND REAGENTS
7.3.1. Overview
7.3.2. Instrument and Reagents Market Forecast and Analysis
7.4. CONSUMABLES
7.4.1. Overview
7.4.2. Consumables Market Forecast and Analysis
8. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TEST TYPE
8.1. OVERVIEW
8.2. TEST TYPE MARKET FORECASTS AND ANALYSIS
8.3. MOLECULAR DIAGNOSTICS
8.3.1. Overview
8.3.2. Molecular Diagnostics Market Forecast and Analysis
8.4. URINALYSIS
8.4.1. Overview
8.4.2. Urinalysis Market Forecast and Analysis
8.5. IMMUNOASSAY
8.5.1. Overview
8.5.2. Immunoassay Market Forecast and Analysis
9. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. DISEASE TESTING
9.3.1. Overview
9.3.2. Disease Testing Market Forecast and Analysis
9.4. DRUG-RESISTANCE TESTING
9.4.1. Overview
9.4.2. Drug-Resistance Testing Market Forecast and Analysis
10. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - INFECTION TYPE
10.1. OVERVIEW
10.2. INFECTION TYPE MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL ACQUIRED PNEUMONIA
10.3.1. Overview
10.3.2. Hospital Acquired Pneumonia Market Forecast and Analysis
10.4. BLOODSTREAM INFECTIONS
10.4.1. Overview
10.4.2. Bloodstream Infections Market Forecast and Analysis
10.5. SURGICAL SITE INFECTIONS
10.5.1. Overview
10.5.2. Surgical Site Infections Market Forecast and Analysis
10.6. GASTROINTESTINAL INFECTIONS
10.6.1. Overview
10.6.2. Gastrointestinal Infections Market Forecast and Analysis
10.7. OTHERS
10.7.1. Overview
10.7.2. Others Market Forecast and Analysis
11. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - END USERS
11.1. OVERVIEW
11.2. END USERS MARKET FORECASTS AND ANALYSIS
11.3. HOSPITAL
11.3.1. Overview
11.3.2. Hospital Market Forecast and Analysis
11.4. CLINICS
11.4.1. Overview
11.4.2. Clinics Market Forecast and Analysis
11.5. OTHERS
11.5.1. Overview
11.5.2. others Market Forecast and Analysis

12. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Hospital Acquired Infections Diagnostics Market Overview
12.1.2 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis
12.1.3 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Product
12.1.4 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Test Type
12.1.5 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Application
12.1.6 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Infection Type
12.1.7 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By End Users
12.1.8 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Countries
12.1.8.1 United States Hospital Acquired Infections Diagnostics Market
12.1.8.1.1 United States Hospital Acquired Infections Diagnostics Market by Product
12.1.8.1.2 United States Hospital Acquired Infections Diagnostics Market by Test Type
12.1.8.1.3 United States Hospital Acquired Infections Diagnostics Market by Application
12.1.8.1.4 United States Hospital Acquired Infections Diagnostics Market by Infection Type
12.1.8.1.5 United States Hospital Acquired Infections Diagnostics Market by End Users
12.1.8.2 Canada Hospital Acquired Infections Diagnostics Market
12.1.8.2.1 Canada Hospital Acquired Infections Diagnostics Market by Product
12.1.8.2.2 Canada Hospital Acquired Infections Diagnostics Market by Test Type
12.1.8.2.3 Canada Hospital Acquired Infections Diagnostics Market by Application
12.1.8.2.4 Canada Hospital Acquired Infections Diagnostics Market by Infection Type
12.1.8.2.5 Canada Hospital Acquired Infections Diagnostics Market by End Users
12.1.8.3 Mexico Hospital Acquired Infections Diagnostics Market
12.1.8.3.1 Mexico Hospital Acquired Infections Diagnostics Market by Product
12.1.8.3.2 Mexico Hospital Acquired Infections Diagnostics Market by Test Type
12.1.8.3.3 Mexico Hospital Acquired Infections Diagnostics Market by Application
12.1.8.3.4 Mexico Hospital Acquired Infections Diagnostics Market by Infection Type
12.1.8.3.5 Mexico Hospital Acquired Infections Diagnostics Market by End Users
12.2. EUROPE
12.2.1 Europe Hospital Acquired Infections Diagnostics Market Overview
12.2.2 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis
12.2.3 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Product
12.2.4 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Test Type
12.2.5 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Application
12.2.6 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Infection Type
12.2.7 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By End Users
12.2.8 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Hospital Acquired Infections Diagnostics Market
12.2.8.1.1 Germany Hospital Acquired Infections Diagnostics Market by Product
12.2.8.1.2 Germany Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.1.3 Germany Hospital Acquired Infections Diagnostics Market by Application
12.2.8.1.4 Germany Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.1.5 Germany Hospital Acquired Infections Diagnostics Market by End Users
12.2.8.2 France Hospital Acquired Infections Diagnostics Market
12.2.8.2.1 France Hospital Acquired Infections Diagnostics Market by Product
12.2.8.2.2 France Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.2.3 France Hospital Acquired Infections Diagnostics Market by Application
12.2.8.2.4 France Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.2.5 France Hospital Acquired Infections Diagnostics Market by End Users
12.2.8.3 Italy Hospital Acquired Infections Diagnostics Market
12.2.8.3.1 Italy Hospital Acquired Infections Diagnostics Market by Product
12.2.8.3.2 Italy Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.3.3 Italy Hospital Acquired Infections Diagnostics Market by Application
12.2.8.3.4 Italy Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.3.5 Italy Hospital Acquired Infections Diagnostics Market by End Users
12.2.8.4 Spain Hospital Acquired Infections Diagnostics Market
12.2.8.4.1 Spain Hospital Acquired Infections Diagnostics Market by Product
12.2.8.4.2 Spain Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.4.3 Spain Hospital Acquired Infections Diagnostics Market by Application
12.2.8.4.4 Spain Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.4.5 Spain Hospital Acquired Infections Diagnostics Market by End Users
12.2.8.5 United Kingdom Hospital Acquired Infections Diagnostics Market
12.2.8.5.1 United Kingdom Hospital Acquired Infections Diagnostics Market by Product
12.2.8.5.2 United Kingdom Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.5.3 United Kingdom Hospital Acquired Infections Diagnostics Market by Application
12.2.8.5.4 United Kingdom Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.5.5 United Kingdom Hospital Acquired Infections Diagnostics Market by End Users
12.2.8.6 Rest of Europe Hospital Acquired Infections Diagnostics Market
12.2.8.6.1 Rest of Europe Hospital Acquired Infections Diagnostics Market by Product
12.2.8.6.2 Rest of Europe Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.6.3 Rest of Europe Hospital Acquired Infections Diagnostics Market by Application
12.2.8.6.4 Rest of Europe Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.6.5 Rest of Europe Hospital Acquired Infections Diagnostics Market by End Users
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Hospital Acquired Infections Diagnostics Market Overview
12.3.2 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis
12.3.3 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Product
12.3.4 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Test Type
12.3.5 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Application
12.3.6 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Infection Type
12.3.7 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By End Users
12.3.8 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Hospital Acquired Infections Diagnostics Market
12.3.8.1.1 Australia Hospital Acquired Infections Diagnostics Market by Product
12.3.8.1.2 Australia Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.1.3 Australia Hospital Acquired Infections Diagnostics Market by Application
12.3.8.1.4 Australia Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.1.5 Australia Hospital Acquired Infections Diagnostics Market by End Users
12.3.8.2 China Hospital Acquired Infections Diagnostics Market
12.3.8.2.1 China Hospital Acquired Infections Diagnostics Market by Product
12.3.8.2.2 China Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.2.3 China Hospital Acquired Infections Diagnostics Market by Application
12.3.8.2.4 China Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.2.5 China Hospital Acquired Infections Diagnostics Market by End Users
12.3.8.3 India Hospital Acquired Infections Diagnostics Market
12.3.8.3.1 India Hospital Acquired Infections Diagnostics Market by Product
12.3.8.3.2 India Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.3.3 India Hospital Acquired Infections Diagnostics Market by Application
12.3.8.3.4 India Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.3.5 India Hospital Acquired Infections Diagnostics Market by End Users
12.3.8.4 Japan Hospital Acquired Infections Diagnostics Market
12.3.8.4.1 Japan Hospital Acquired Infections Diagnostics Market by Product
12.3.8.4.2 Japan Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.4.3 Japan Hospital Acquired Infections Diagnostics Market by Application
12.3.8.4.4 Japan Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.4.5 Japan Hospital Acquired Infections Diagnostics Market by End Users
12.3.8.5 South Korea Hospital Acquired Infections Diagnostics Market
12.3.8.5.1 South Korea Hospital Acquired Infections Diagnostics Market by Product
12.3.8.5.2 South Korea Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.5.3 South Korea Hospital Acquired Infections Diagnostics Market by Application
12.3.8.5.4 South Korea Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.5.5 South Korea Hospital Acquired Infections Diagnostics Market by End Users
12.3.8.6 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market
12.3.8.6.1 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market by Product
12.3.8.6.2 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.6.3 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market by Application
12.3.8.6.4 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.6.5 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market by End Users
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Hospital Acquired Infections Diagnostics Market Overview
12.4.2 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis
12.4.3 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Product
12.4.4 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Test Type
12.4.5 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Application
12.4.6 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Infection Type
12.4.7 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By End Users
12.4.8 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Hospital Acquired Infections Diagnostics Market
12.4.8.1.1 South Africa Hospital Acquired Infections Diagnostics Market by Product
12.4.8.1.2 South Africa Hospital Acquired Infections Diagnostics Market by Test Type
12.4.8.1.3 South Africa Hospital Acquired Infections Diagnostics Market by Application
12.4.8.1.4 South Africa Hospital Acquired Infections Diagnostics Market by Infection Type
12.4.8.1.5 South Africa Hospital Acquired Infections Diagnostics Market by End Users
12.4.8.2 Saudi Arabia Hospital Acquired Infections Diagnostics Market
12.4.8.2.1 Saudi Arabia Hospital Acquired Infections Diagnostics Market by Product
12.4.8.2.2 Saudi Arabia Hospital Acquired Infections Diagnostics Market by Test Type
12.4.8.2.3 Saudi Arabia Hospital Acquired Infections Diagnostics Market by Application
12.4.8.2.4 Saudi Arabia Hospital Acquired Infections Diagnostics Market by Infection Type
12.4.8.2.5 Saudi Arabia Hospital Acquired Infections Diagnostics Market by End Users
12.4.8.3 U.A.E Hospital Acquired Infections Diagnostics Market
12.4.8.3.1 U.A.E Hospital Acquired Infections Diagnostics Market by Product
12.4.8.3.2 U.A.E Hospital Acquired Infections Diagnostics Market by Test Type
12.4.8.3.3 U.A.E Hospital Acquired Infections Diagnostics Market by Application
12.4.8.3.4 U.A.E Hospital Acquired Infections Diagnostics Market by Infection Type
12.4.8.3.5 U.A.E Hospital Acquired Infections Diagnostics Market by End Users
12.4.8.4 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market
12.4.8.4.1 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market by Product
12.4.8.4.2 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market by Test Type
12.4.8.4.3 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market by Application
12.4.8.4.4 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market by Infection Type
12.4.8.4.5 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market by End Users
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Hospital Acquired Infections Diagnostics Market Overview
12.5.2 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis
12.5.3 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Product
12.5.4 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Test Type
12.5.5 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Application
12.5.6 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Infection Type
12.5.7 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By End Users
12.5.8 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Hospital Acquired Infections Diagnostics Market
12.5.8.1.1 Brazil Hospital Acquired Infections Diagnostics Market by Product
12.5.8.1.2 Brazil Hospital Acquired Infections Diagnostics Market by Test Type
12.5.8.1.3 Brazil Hospital Acquired Infections Diagnostics Market by Application
12.5.8.1.4 Brazil Hospital Acquired Infections Diagnostics Market by Infection Type
12.5.8.1.5 Brazil Hospital Acquired Infections Diagnostics Market by End Users
12.5.8.2 Argentina Hospital Acquired Infections Diagnostics Market
12.5.8.2.1 Argentina Hospital Acquired Infections Diagnostics Market by Product
12.5.8.2.2 Argentina Hospital Acquired Infections Diagnostics Market by Test Type
12.5.8.2.3 Argentina Hospital Acquired Infections Diagnostics Market by Application
12.5.8.2.4 Argentina Hospital Acquired Infections Diagnostics Market by Infection Type
12.5.8.2.5 Argentina Hospital Acquired Infections Diagnostics Market by End Users
12.5.8.3 Rest of South and Central America Hospital Acquired Infections Diagnostics Market
12.5.8.3.1 Rest of South and Central America Hospital Acquired Infections Diagnostics Market by Product
12.5.8.3.2 Rest of South and Central America Hospital Acquired Infections Diagnostics Market by Test Type
12.5.8.3.3 Rest of South and Central America Hospital Acquired Infections Diagnostics Market by Application
12.5.8.3.4 Rest of South and Central America Hospital Acquired Infections Diagnostics Market by Infection Type
12.5.8.3.5 Rest of South and Central America Hospital Acquired Infections Diagnostics Market by End Users

13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

14. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET, KEY COMPANY PROFILES
14.1. ABBOTT LABORATORIES
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ADVANDX
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. ALERE INC.
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. ASTRAZENECA PLC
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. BECTON DICKINSON AND COMPANY
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. HOLOGIC, INC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. BAYER SCHERING PHARMA LLC
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. CEPHEID INC
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. ROCHE AG
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. DAIICHI SANKYO
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments

15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. AdvanDX
3. Alere Inc.
4. AstraZeneca Plc
5. Becton Dickinson and Company
6. Hologic, Inc
7. Bayer Schering Pharma LLC
8. Cepheid Inc
9. Roche AG
10. Daiichi Sankyo
TIPRE00016871
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking